Open Access[Use of tenofovir monotherapy in a cohort of prisoners confined in the prisons of the Molise region and affected by mild HBV-related chronic hepatitis]
Author(s) -
R. Patriarchi,
Antonio Di Nicola,
Orazio Grassi,
Giuseppe De Bartolomeo
Publication year - 2015
Publication title -
clinical management issues
Language(s) - English
Resource type - Journals
eISSN - 2283-3137
pISSN - 1973-4832
DOI - 10.7175/cmi.v9i4.1218
Subject(s) - medicine , tenofovir , chronic hepatitis , cohort , population , hepatitis b virus , hepatitis b , virology , virus , human immunodeficiency virus (hiv) , environmental health
Inmates are a population at risk for hepatitis B virus infection. It affects about 2% of Italian prisoners, while the prevalence in the Molise region seems to be higher, accounting for around 4% of the inmates.The Authors report their experience in a penitentiary in the management of chronic hepatitis B with tenofovir. In particular, 10 male patients affected by HBV-related chronic hepatitis naïves to treatment confined in the prisons of the Molise region were treated with tenofovir 245 mg/die. The results show a satisfactory response, excellent tolerance, and no interruptions.[Article in Italian